A Twitter account in the hands of a hothead startup founder can be a dangerous thing.
The New York Times ran a piece Sunday looking into why a 62-year-old pill saw its price skyrocket from $13.50 to nearly $750 after it was acquired by Turing Pharmaceuticals last month.
The increase in the price of Daraprim, a drug that the Times reported “is the standard of care for treating a… Read More...